AMBUB DC

Ambu A/S

Healthcare


Presented:07/01/2021
Price:DKK237.30
Cap:$8.99B
Current Price:DKK128.00
Cap:$5.09B

Presented

Date07/01/2021
PriceDKK237.30
Market Cap$8.99B
Ent Value$11.20B
P/E Ratio209.85x
Book ValueDKK15.23
Div Yield0.12%
Shares O/S253.64M
Ave Daily Vol837,304
Short IntN/A

Current

PriceDKK128.00
Market Cap$5.09B
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.

Publicly traded companies mentioned herein: Ambu A/S (AMBUB DC), Boston Scientific Corp (BSX), Hoya Corp (7741 JP), Olympus Corp (7733 JP)

Highlights 

The presenter is short shares of Ambu A/S (AMBUB DC), a Danish MedTech company focused on developing disposable scopes used in endoscopy (mainly bronchoscopes) and gastrointestinal procedures.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.